Dr. Henrike Brundiek ist the new Head of R&D at Enzymicals AG

27-Apr-2017 - Germany

Dr. Brundiek is a long-term employee of Enzymicals AG and takes over the scientific management of the company from now on. The former CSO, Dr. Rainer Wardenga, steps down from the managing board due to a longer-term parental leave. This decision was made by mutual agreement between the bodies of Enzymicals AG and reflects the family-friendliness of the company.

Enzymicals AG

Dr. Henrike Brundiek

With this restructuring, Dr. Ulf Menyes is the company's sole managing director. He will be supported by Steffen Weber, a long-term colleague and qualified economist.

Dr. Wardenga will focus on management of business development after parental leave. The reorganization of these responsibilities takes into account the steady growth of the company.

Other news from the department people

More news from our other portals

So close that even
molecules turn red...